DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Otros (Other)
Lipid rafts, cholesterol and apoptosis in cancer and neurodegenerative diseases
The dynamic nature of membrane along with an uneven distribution of lipids leads to the formation of specialized membrane domains where proteins can selectively be included or excluded. In this regard, the dynamic and preferential clustering and packing of sphingolipids and cholesterol into moving platforms, named as lipid rafts, form membrane domains that act as scaffolds for the attachment of specific proteins and for the proper functioning of a number of signaling cascades. Lipid rafts harbor several signaling routes that promote cell survival and proliferation, and thereby they could play a role in the development of cancer. On the other hand, evidences in the last decade have shown that lipid rafts can also serve as organizing centers for the assembly of apoptotic and signaling molecules involved in cell death, thus opening a new avenue in cancer therapy. Recruitment of death receptors and downstream apoptotic signaling molecules in aggregated lipid rafts has led to the emerging concept of a plasma membrane platform designated as “cluster of apoptotic signaling molecule-enriched rafts” (CASMER) that may play a role in the regulation of apoptosis. In addition, lipid rafts also play a major role in neurotoxicity, including the production and aggregation of amyloid-β peptide (Aβ) to form neurotoxic Aβ oligomers in the brain, which are widely believed to drive Alzheimer’s disease pathology. Alterations in cholesterol have been detected in cell models for cancer and neurodegenerative diseases, which might lead to changes in cholesterol-rich rafts and thereby in the regulation of cell death or survival. However, it is currently unclear what the potential mechanisms underlying cholesterol perturbations are. Growing evidence suggests that compartmentalization of macrocomplexes and signaling routes in lipid rafts has a crucial role in the regulation of cell fate, being of major importance in different pathologies, including cancer and neurodegenerative diseases. Despite the underlying mechanisms and functional impact of protein compartmentalization are still not well understood, the modulation of lipid rafts opens new approaches in the treatment of these diseases for which current available therapies are not satisfactory., This work was supported by grants from the Spanish Ministerio de Ciencia e Innovación (SAF2008-02251, SAF2011-30518, and RD06/0020/1037 from Red Temática de Investigación Cooperativa en Cáncer, Instituto de Salud Carlos III, cofunded by the Fondo Europeo de Desarrollo Regional of the European Union), European Community’s Seventh Framework Programme FP7-2007-2013 (grant HEALTH-F2-2011-256986), Junta de Castilla y León (CSI052A11-2, GR15-Experimental Therapeutics and Translational Oncology Program, Biomedicine Project 2009, and Biomedicine Project 2010-2011) to F.M.; grants from the Fondo de Investigación Sanitaria and European Commission (FIS-FEDER 06/0813, PS09/01915) to C.G. C.G. is supported by the Ramón y Cajal Program from the Spanish Ministerio de Ciencia e Innovación., Peer Reviewed
Proyecto:
EC / FP7 256986